A 60‑year‑old with HFrEF (EF 30%) on β‑blocker and SGLT2 inhibitor remains symptomatic. BP 118/70. Creatinine 88 µmol/L, K⁺ 4.6. Which addition offers...

Question

A 60‑year‑old with HFrEF (EF 30%) on β‑blocker and SGLT2 inhibitor remains symptomatic. BP 118/70. Creatinine 88 µmol/L, K⁺ 4.6. Which addition offers mortality benefit?

Accepted Answer

Start sacubitril/valsartan

Answer

Add verapamil

Answer

Start isosorbide mononitrate alone

Answer

Start ivabradine first

Answer

Add hydroxyzine for sleep

Heart Failure-GDMT Optimization — MRCP Part 1 MCQ

A 60‑year‑old with HFrEF (EF 30%) on β‑blocker and SGLT2 inhibitor remains symptomatic. BP 118/70. Creatinine 88 µmol/L, K⁺ 4.6. Which addition offers mortality benefit?